Bladder Disorders

A 2-month-old male in the neonatal intensive care unit (NICU), born at 24 weeks 1 day of gestation, presented for evaluation of recurrent urinary tract infections.

The FDA has approved mitomycin intravesical solution for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer.

The authors present case of a 56-year-old man with gross hematuria with emphasis placed on the diagnostic work-up, referral, and use of CT urogram.